Europe

The Biotech VC View: What Does 2019 Hold For European Health Startups?
Forbes
Mon, 01/21/19 - 11:55 pm
Europe
biotech
venture capital
Brexit and beyond: the challenges ahead for pharma
Pharmaforum
Fri, 01/18/19 - 12:08 am
Brexit
UK
Europe
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
CP Wire
Wed, 01/16/19 - 10:03 am
Janssen
JNJ
Erleada
prostate cancer
Europe
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
Fierce Biotech
Tue, 01/15/19 - 11:09 am
EMA
Europe
Brexit
UK
Amsterdam
US loses, EU wins as Chinese biotech investment shifts focus
Pharmaforum
Wed, 01/2/19 - 10:02 am
China
Europe
biotech
Why The U.S. Remains The World’s Most Expensive Market For ‘Biologic’ Drugs
KHN
Fri, 12/21/18 - 10:13 am
biologics
United States
Europe
Merck bags adjuvant okay for Keytruda in melanoma
Pharmaforum
Tue, 12/18/18 - 10:13 am
Merck
Europe
Keytruda
melanoma
The Great Pharma Brexit? An Endpoints News snap poll finds most life sciences insiders predicting a debacle for the industry
Endpoints
Tue, 12/4/18 - 09:55 am
pharma industry
UK
Europe
Brexit
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
CP Wire
Tue, 12/4/18 - 09:36 am
Clovis Oncology
Europe
Rubraca
How Pharmaceuticals Impact the Environment: EMA Revises Guideline
RAPS.org
Sat, 12/1/18 - 11:56 am
Europe
EMA
environmental concerns
Novartis’ Gilenya gets approval in Europe to treat children and adolescents with MS
Pharmaceutical Business Review
Fri, 11/30/18 - 10:21 am
Novartis
Gilenya
Europe
Relapsing Remitting Multiple Sclerosis
FDA to Follow EMA With Move From London to Amsterdam
RAPS.org
Thu, 11/29/18 - 07:32 pm
FDA
Amsterdam
EMA
Europe
European Commission Approves Kalydeco to Treat Cystic Fibrosis
CP Wire
Thu, 11/29/18 - 09:35 am
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Europe
Luxturna cleared for sale in Europe, but payer support uncertain
Biopharma Dive
Mon, 11/26/18 - 11:15 pm
Spark Therapeutics
Luxturna
Europe
gene therapy
Pharma hopes for best, fears the worst, as Brexit vote nears
Pharmaforum
Mon, 11/26/18 - 12:34 pm
Brexit
UK
Europe
pharma industry
Novartis/Spark’s sight gene therapy approved in EU
Pharmaforum
Fri, 11/23/18 - 01:16 pm
Novartis
Spark Therapeutics
Luxturna
gene therapy
Europe
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Endpoints
Tue, 11/20/18 - 12:17 pm
Takeda
shareholders
Japan
M&A
Shire
Europe
Novartis focusing on cutting CAR-T costs ahead of EU launches
Pharmaforum
Tue, 11/20/18 - 11:51 am
Novartis
CAR-T
Europe
What a draft Brexit agreement means for the medical device industry
Emergo
Mon, 11/19/18 - 09:52 am
devices
UK
Europe
Brexit
Edwards Lifesciences wins CE Mark for Sapien 3 Ultra TAVR
Mass Device
Fri, 11/16/18 - 10:03 am
Edwards Lifesciences
CE Mark
Europe
Sapien 3
TAVR
devices

Pages